Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Trial · NCT01950819
Adverse events1,650
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,650
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Everolimus Plus@Reduced CNI | 227 | 1,014 | |
| other | Anaemia | Blood and lymphatic system disorders | MPA Plus Standard@CNI | 238 | 1,012 | |
| other | Leukocytosis | Blood and lymphatic system disorders | Everolimus Plus@Reduced CNI | 24 | 1,014 | |
| other | Leukocytosis | Blood and lymphatic system disorders | MPA Plus Standard@CNI | 58 | 1,012 | |
| other | Leukopenia | Blood and lymphatic system disorders | Everolimus Plus@Reduced CNI | 94 | 1,014 | |
| other | Leukopenia | Blood and lymphatic system disorders | MPA Plus Standard@CNI | 194 | 1,012 | |
| other | Polycythaemia | Blood and lymphatic system disorders | Everolimus Plus@Reduced CNI | 52 | 1,014 | |
| other | Polycythaemia | Blood and lymphatic system disorders | MPA Plus Standard@CNI | 42 | 1,012 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Everolimus Plus@Reduced CNI | 74 | 1,014 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | MPA Plus Standard@CNI | 41 | 1,012 | |
| other | Tachycardia | Cardiac disorders | Everolimus Plus@Reduced CNI | 53 | 1,014 | |
| other | Tachycardia | Cardiac disorders | MPA Plus Standard@CNI | 52 | 1,012 | |
| other | Abdominal pain | Gastrointestinal disorders | Everolimus Plus@Reduced CNI | 94 | 1,014 | |
| other | Abdominal pain | Gastrointestinal disorders | MPA Plus Standard@CNI | 104 | 1,012 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Everolimus Plus@Reduced CNI | 39 | 1,014 | |
| other | Abdominal pain upper | Gastrointestinal disorders | MPA Plus Standard@CNI | 62 | 1,012 | |
| other | Constipation | Gastrointestinal disorders | Everolimus Plus@Reduced CNI | 245 | 1,014 | |
| other | Constipation | Gastrointestinal disorders | MPA Plus Standard@CNI | 242 | 1,012 | |
| other | Diarrhoea | Gastrointestinal disorders | Everolimus Plus@Reduced CNI | 242 | 1,014 | |
| other | Diarrhoea | Gastrointestinal disorders | MPA Plus Standard@CNI | 318 | 1,012 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01950819/events